Stocks to Watch: Nanosphere, Sinclair Broadcast Group, Groupon, Keryx Biopharmaceuticals

Lakeway, NY -- (SBWIRE) -- 03/04/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Nanosphere, Inc. (NASDAQ:NSPH) shares climbed 13.85% and closed at $2.22. The company announced that an overview of the company's business and commercial strategy will be given by Nanosphere's President and Chief Executive Officer Michael McGarrity at the Cowen and Company 33rd Annual Health Care Conference, being held at the Boston Marriott Copley Place in Boston, Massachusetts. The Company presentation is on Tuesday, March 5 at 11:20am-11:50am Eastern Time.

Get Latest News, Updates on NSPH Here

Sinclair Broadcast Group, Inc. (NASDAQ:SBGI) shares increased 12.64% to $15.86 in yesterday’s session. The company, last week, announced plans to buy 18 television stations owned by Barrington Broadcasting Group for $370 million.

Additionally, the company also announced last week that it reached an agreement with DirecTV that allows the satellite company to continue to carry Sinclair-owned stations and their programs. Sinclair had warned that DirecTV customers could lose access to stations, such as WBFF Fox 45 and WNUV The CW in Baltimore, if the companies failed to renegotiate a contract that expired Thursday.

Is SBGI a Strong Buying Opportunity After The Recent Gain? Find out Here

Groupon Inc (NASDAQ:GRPN) stock gained 12.58% to $5.10. The company, last week, reported a fourth quarter net loss of $0.12 per share which was flat with the prior year result. The consensus estimate was for a loss of $0.03. Revenues grew 30 percent to $638.3 million from $492.2 million last year. The consensus estimate was for revenues of $638.4 million.

Additionally, the company announced that Jason Child, Chief Financial Officer, will present at the Deutsche Bank dbAccess Media & Telecommunications Conference on Tuesday, March 5 at 2:05PM (EST) at The Breakers Hotel in Palm Beach, Florida.

Is GRPN Signaling a Buy After The Solid gain? Don’t Miss Out Free Trend Analysis Here

Keryx Biopharmaceuticals (NASDAQ:KERX) shares climbed 11.82% and closed at $7.19. The company, on Feb. 22, announced that Ron Bentsur, the Company’s Chief Executive Officer, will be presenting at the Citigroup 2013 Global Healthcare Conference, being held February 25-27, 2013, in New York City. Mr. Bentsur’s presentation is scheduled to take place on Wednesday, February 27th, at 2:15 PM ET.

Is KERX a Strong Buying Opportunity After The Recent Surge? Get Free Trend Analysis Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.